A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer

Author:

de Vos-Geelen Judith1ORCID,Hoebers Frank J. P.2,Geurts Sandra M. E.1,Hoeben Ann1,de Greef Bianca T. A.3,Voncken Francine E. M.4,Bogers J. (Hans) A.5,Braam Pètra M.6,Muijs C. (Kristel) T.7,de Jong Martin A.8,Kasperts Nicolien9,Rozema Tom10ORCID,Jeene Paul M.1112ORCID,Blom Gerrit J.13,van Dieren Jolanda M.14,Hulshof Maarten C. C. M.11,van Laarhoven Hanneke W. M.15ORCID,Grabsch Heike I.1617,Lemmens Valery E. P. P.1819ORCID,Tjan-Heijnen Vivianne C. G.1ORCID,Nieuwenhuijzen Grard A. P.20ORCID

Affiliation:

1. Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands;

2. Department of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands;

3. Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center, Maastricht, The Netherlands;

4. Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands;

5. Radiotherapiegroep Arnhem, Arnhem, The Netherlands;

6. Department of Radiotherapy, Nijmegen, The Netherlands;

7. Department of Radiotherapy, University Medical Center Groningen, Groningen, The Netherlands;

8. Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands;

9. Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands;

10. Insituut Verbeeten, Tilburg, The Netherlands;

11. Department of Radiotherapy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands;

12. Radiotherapiegroep, Deventer, The Netherlands;

13. Department of Radiation Oncology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands;

14. Department of Gastrointestinal Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands;

15. Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands;

16. Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands;

17. Pathology & Data Analytics, Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds, UK;

18. Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), The Netherlands;

19. Department of Public Health, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands;

20. Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3